Chronic Myelomonocytic Leukemia — Trials

Chronic Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 86
Recruiting: 51
Ph III recruiting: 3
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05488548	Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies	recruiting	Phase 1	75	Epigenetix, Inc.INDUSTRY	1	Jan 14, 2025	clinicaltrials
NCT06111612	Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement	recruiting	—	50	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Jul 22, 2024